Medical Device Company to Create 2,000 Jobs in Costa Rican Expansion

Share this article

MicroVention-Terumo, a U.S.-Japanese company in the life sciences sector, announced that it will expand its Costa Rican operations with the construction of a new plant in Alajuela’s Coyol Free Zone. The 20,000 square-meter facilities will generate 2,000 more jobs in various administrative, operational, and engineering areas.

MicroVention currently employs 1,700 workers in Costa Rica; its newest investment will reach almost US$80 million by the end of 2022.

The announcement was made during a visit to the company’s facilities by the President of the Republic, Carlos Alvarado; the Minister of Foreign Trade, Andrés Valenciano; and the Managing Director of CINDE, Jorge Sequeira.

After reiterating the government’s support for foreign direct investment and the Free Trade Zone regime, Alvarado commented, “MicroVention’s announcement to increase its payroll by 2,000 jobs and open a third plant, represents a significant impact on this generation of quality employment in Costa Rica.” President Alvarado highlighted the inter-institutional work that has been done, and which will be further strengthened by the new INA Law, to train Costa Ricans and prepare them for greater employment opportunities.

“Microvention started operation in Costa Rica more than 7 years ago and has recognized the great potential of our family of professionals and direct, manufacturing associates. Our success in Costa Rica has grown MicoVention into what now is now our 3rd expansion in the country. Today our strategic vision is that we will be ending 2022 with close to 35,000 sq. meters in manufacturing space and 3,000 associates. We are very proud of shipping Costa Rica made products to doctors around the world. Thus, helping our patients have a better quality of life,” said Charlie Noel, Vice President of International Operations, Microvention.

In Costa Rica, the company manages two manufacturing plants dedicated to creating medical devices used in endovascular therapies, for the treatment of vascular and brain diseases.

Those who currently are job seeking can visit:

Print Friendly, PDF & Email


Popular Content